A
Aytu BioPharma D
D
AYTU
1.91000
USD
-0.06
(-2.95%)
مغلق
حجم التداول
1,427
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
18,931,754
الأخبار المقالات
العنوان: Aytu BioPharma
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.